Viewing Study NCT02076412

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 10:46 PM

Ignite Modification Date: 2025-12-26 @ 10:46 PM

Study NCT ID: NCT02076412

Status: COMPLETED

Last Update Posted: 2019-01-25

First Post: 2014-02-26

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Sponsor: Rigel Pharmaceuticals

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module